Drug intelligence / Profile preview

recombinant collagen protein

Development stage: Preclinical
Lead developer: Anhui Chuangjian Medical Devices
Modality: Recombinant Proteins and Enzymes
Administration: Ophthalmic

Overview

Recombinant collagen protein is a biological substance used in a lubricating solution for contact lenses. Its primary function is to alleviate dryness and discomfort experienced by individuals wearing contact lenses. The protein likely acts by providing lubrication and potentially enhancing the natural tear film to improve ocular surface comfort. It is being developed by companies specializing in medical devices and technology for ophthalmic applications.

Beyond the preview

Go deeper on recombinant collagen protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant collagen protein.

Explore the full profile